Progenics Pharmaceuticals CEO Paul Maddon receives $4.6M in 2006
Progenics Pharmaceuticals reports 2006 executive compensation
By ExecPay News
Published: April 27, 2007
Progenics Pharmaceuticals reported fiscal year 2006 executive compensation information on April 27, 2007.
In 2006, five executives at Progenics Pharmaceuticals received on average a compensation package of $1.7M.
Average pay of disclosed executives at Progenics Pharmaceuticals
Paul J. Maddon, Chief Executive Officer, received $4.6M in total. 62% of Maddon's compensation, or $2.8M, was in option awards. Maddon also received $402K in bonus, $565K in salary, $786K in stock awards, as well as $16K in other compensation.
Mark R. Baker, General Counsel, received a compensation package of $1M. 48% of the compensation package, or $504K, was in option awards.
Thomas A. Boyd, Senior Vice President, Product Development, earned $1M in 2006.
Alton B. Kremer, Vice President, Clinical Research, received $885K in 2006.
Robert A. McKinney, Chief Financial Officer, earned $774K in 2006.
Related executives
Paul Maddon
Progenics Pharmaceuticals
Chief Executive Officer
Robert McKinney
Progenics Pharmaceuticals
Chief Financial Officer
Mark Baker
Progenics Pharmaceuticals
General Counsel
Thomas Boyd
Progenics Pharmaceuticals
Senior Vice President, Product Development
Alton Kremer
Progenics Pharmaceuticals
Vice President, Clinical Research
You may also like
Source: SEC filing on April 27, 2007.